Managed care
Southern California Permanente Medical Group
Southern California Permanente Medical Group was paid $42.84M by Medicaid between Jan 2018 and Dec 2024, across 380 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 19% of everything it billed.
33Billing provider infoSOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
SAN DIEGO, CA 92120
SAN DIEGO, CA 92120
33aNPI1225060742assigned 07/07/2006
33bProvider typeHealth Maintenance Organization
28Total paid$42.84M
24GClaims1,931,346
24DCodes billed380
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Health Maintenance Organization providers in California
Rank by total paid#4 of 151
Median peer was paid$59K
This provider vs. median725×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIDOFF, RAMIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 204,323 | $188K | |
| 2019 | 249,520 | $494K | |
| 2020 | 175,009 | $2.27M | |
| 2021 | 261,370 | $5.23M | |
| 2022 | 293,764 | $6.92M | |
| 2023 | 345,106 | $10.63M | |
| 2024incomplete | 402,254 | $17.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 138,827 | 135,166 | $8.15M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.2% | 31,208 | 31,034 | $3.53M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.4% | 14,750 | 14,642 | $2.31M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.1% | 156,005 | 151,012 | $2.19M |
| 91320 | 4.9% | 14,339 | 14,333 | $2.10M | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 4.2% | 41,550 | 31,323 | $1.81M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.3% | 10,084 | 8,959 | $1.40M |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 2.9% | 29,002 | 28,042 | $1.25M |
| 90480 | 1.9% | 18,603 | 18,574 | $831K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.9% | 152,621 | 151,830 | $823K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.9% | 6,931 | 4,869 | $820K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.6% | 31,227 | 21,321 | $682K |
368 more codes
| 90662 | 1.2% | 5,139 | $517K | |
| 71046 | Radiologic examination, chest; 2 views | 1.0% | 54,412 | $447K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 4,967 | $375K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 25,363 | $374K |
| 92015 | Determination of refractive state | <1% | 47,449 | $363K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 2,238 | $363K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 6,670 | $357K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 687 | $339K |
| 92002 | <1% | 9,760 | $310K | |
| 90686 | <1% | 67,522 | $279K | |
| 82565 | <1% | 57,848 | $274K | |
| 77080 | <1% | 8,972 | $272K | |
| 0002A | <1% | 6,367 | $241K | |
| 0001A | <1% | 6,475 | $240K | |
| 0064A | <1% | 5,751 | $236K | |
| 73630 | <1% | 25,109 | $234K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 2,966 | $231K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 12,154 | $230K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 11,908 | $228K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 2,153 | $219K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,041 | $201K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 8,279 | $200K |
| 73562 | <1% | 14,367 | $199K | |
| 83880 | <1% | 3,227 | $195K | |
| 95800 | <1% | 1,176 | $195K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 28,927 | $193K |
| 0012A | <1% | 4,825 | $187K | |
| 0011A | <1% | 4,775 | $182K | |
| 80051 | <1% | 31,135 | $178K | |
| 73564 | <1% | 8,207 | $177K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 1,622 | $175K |
| 76641 | <1% | 4,963 | $172K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 824 | $171K |
| 93880 | <1% | 622 | $167K | |
| 73030 | <1% | 12,004 | $165K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 2,534 | $162K |
| 84460 | <1% | 39,978 | $160K | |
| 71045 | Radiologic examination, chest; single view | <1% | 31,820 | $160K |
| 0124A | <1% | 4,383 | $145K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 759 | $142K |
| 72100 | <1% | 8,510 | $137K | |
| 90837 | Psychotherapy session, about an hour | <1% | 3,802 | $129K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,479 | $128K |
| 76770 | <1% | 3,235 | $125K | |
| 73610 | <1% | 15,078 | $124K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 9,642 | $123K |
| 93970 | <1% | 1,001 | $118K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 5,482 | $117K |
| 97597 | <1% | 1,093 | $113K | |
| 76380 | <1% | 913 | $113K | |
| 92551 | <1% | 36,454 | $111K | |
| 73130 | <1% | 10,402 | $111K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 1,186 | $105K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 839 | $104K |
| J0178 | Injection, aflibercept, 1 mg | <1% | 39 | $104K |
| 0004A | <1% | 2,550 | $103K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 4,485 | $101K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,766 | $98K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 446 | $97K |
| 73502 | <1% | 3,600 | $96K | |
| 76536 | <1% | 1,872 | $94K | |
| 90674 | <1% | 7,531 | $93K | |
| 0054A | <1% | 2,143 | $89K | |
| 73110 | <1% | 8,329 | $88K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 6,266 | $86K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,651 | $85K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 672 | $84K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 1,101 | $84K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 4,473 | $81K |
| 76830 | Ultrasound, transvaginal | <1% | 3,284 | $80K |
| 84075 | <1% | 19,016 | $80K | |
| 93971 | <1% | 1,015 | $78K | |
| 0134A | <1% | 2,066 | $78K | |
| 82247 | <1% | 20,396 | $77K | |
| 71250 | <1% | 529 | $76K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 3,057 | $75K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 3,742 | $75K |
| 81229 | <1% | 300 | $73K | |
| 99443 | <1% | 739 | $73K | |
| 0071A | <1% | 1,789 | $72K | |
| 74170 | <1% | 190 | $72K | |
| 72141 | <1% | 529 | $64K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,336 | $63K |
| 72050 | <1% | 2,973 | $62K | |
| 73140 | <1% | 8,686 | $62K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 22,607 | $59K |
| 70486 | <1% | 892 | $59K | |
| 52000 | <1% | 175 | $58K | |
| 0072A | <1% | 1,415 | $57K | |
| 84132 | <1% | 13,677 | $56K | |
| 73221 | <1% | 488 | $54K | |
| 84520 | <1% | 16,532 | $54K | |
| 74178 | <1% | 95 | $54K | |
| 99223 | Prolong inpt eval add15 m | <1% | 472 | $53K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 3,031 | $52K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,535 | $52K |
| 93923 | <1% | 271 | $52K | |
| 84295 | <1% | 11,176 | $48K | |
| 77066 | Tomosynthesis, mammo | <1% | 537 | $48K |
| 84450 | <1% | 11,297 | $47K | |
| 81003 | <1% | 32,963 | $47K | |
| 82310 | <1% | 8,299 | $46K | |
| 77065 | Tomosynthesis, mammo | <1% | 534 | $45K |
| 99442 | <1% | 1,247 | $45K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 867 | $43K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 21,861 | $42K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,622 | $40K |
| 85610 | <1% | 10,208 | $38K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,776 | $38K |
| 92523 | <1% | 501 | $37K | |
| 76813 | <1% | 1,155 | $37K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,032 | $37K |
| 97162 | <1% | 451 | $36K | |
| 99441 | <1% | 5,603 | $35K | |
| 99421 | <1% | 11,256 | $35K | |
| 90656 | <1% | 5,900 | $34K | |
| 93296 | <1% | 672 | $34K | |
| 82947 | <1% | 13,892 | $34K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 804 | $33K |
| 73080 | <1% | 3,512 | $33K | |
| 71101 | <1% | 1,520 | $32K | |
| 73100 | <1% | 3,435 | $32K | |
| 11721 | <1% | 337 | $32K | |
| 92557 | <1% | 802 | $31K | |
| 73522 | <1% | 839 | $31K | |
| 74018 | <1% | 6,981 | $30K | |
| 99283 | Emergency room visit (moderate) | <1% | 650 | $30K |
| 84484 | <1% | 2,631 | $30K | |
| 11055 | <1% | 283 | $30K | |
| 81329 | <1% | 937 | $28K | |
| 20610 | <1% | 377 | $28K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,522 | $28K |
| 54150 | <1% | 258 | $28K | |
| 70491 | <1% | 151 | $27K | |
| 97161 | <1% | 528 | $26K | |
| 73590 | <1% | 2,389 | $26K | |
| 93295 | <1% | 390 | $25K | |
| 84702 | <1% | 6,446 | $25K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 557 | $25K |
| 83690 | <1% | 6,767 | $24K | |
| 73660 | <1% | 2,405 | $23K | |
| 91319 | <1% | 767 | $22K | |
| 72070 | <1% | 1,342 | $21K | |
| 99422 | <1% | 3,238 | $21K | |
| 92567 | <1% | 1,263 | $21K | |
| 73560 | <1% | 1,498 | $20K | |
| 64566 | <1% | 106 | $20K | |
| 94729 | <1% | 201 | $20K | |
| 0154A | <1% | 499 | $19K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 146 | $17K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 91 | $17K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,731 | $17K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12,832 | $16K |
| 90694 | <1% | 142 | $16K | |
| 72110 | <1% | 438 | $16K | |
| 93271 | <1% | 54 | $15K | |
| 0031A | <1% | 397 | $15K | |
| 73090 | <1% | 1,829 | $15K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 256 | $14K |
| J7999 | Compounded drug, not otherwise classified | <1% | 264 | $14K |
| 72040 | <1% | 766 | $14K | |
| 96900 | <1% | 541 | $14K | |
| 93294 | <1% | 195 | $13K | |
| 91318 | <1% | 712 | $13K | |
| 99173 | <1% | 20,822 | $12K | |
| 0013A | <1% | 294 | $12K | |
| 76706 | <1% | 177 | $12K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 725 | $12K |
| 87799 | <1% | 373 | $11K | |
| 90750 | <1% | 130 | $10K | |
| 0081A | <1% | 252 | $10K | |
| 85014 | <1% | 5,749 | $10K | |
| 0003A | <1% | 231 | $9K | |
| 94010 | <1% | 207 | $9K | |
| 90670 | <1% | 1,027 | $9K | |
| 0082A | <1% | 217 | $8K | |
| 85379 | <1% | 1,004 | $8K | |
| 83921 | <1% | 373 | $8K | |
| 72170 | <1% | 565 | $8K | |
| 73552 | <1% | 228 | $8K | |
| 0051A | <1% | 199 | $8K | |
| 71271 | <1% | 37 | $8K | |
| 98968 | <1% | 367 | $8K | |
| 86360 | <1% | 171 | $8K | |
| 90732 | <1% | 53 | $8K | |
| 72197 | <1% | 30 | $8K | |
| 85018 | <1% | 3,742 | $8K | |
| 85027 | <1% | 1,673 | $7K | |
| 0074A | <1% | 217 | $7K | |
| 82248 | <1% | 2,095 | $7K | |
| 90677 | <1% | 177 | $7K | |
| 99221 | <1% | 177 | $7K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 15,556 | $7K |
| 0052A | <1% | 171 | $7K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 142 | $7K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 606 | $7K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 748 | $7K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 235 | $7K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 75 | $7K |
| 92504 | <1% | 187 | $6K | |
| 73000 | <1% | 650 | $6K | |
| 86359 | <1% | 171 | $6K | |
| 95819 | <1% | 101 | $6K | |
| 72156 | <1% | 29 | $6K | |
| 90651 | <1% | 288 | $6K | |
| 77072 | <1% | 1,427 | $6K | |
| 0111A | <1% | 153 | $6K | |
| 0112A | <1% | 144 | $6K | |
| 90734 | <1% | 100 | $6K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 93 | $5K |
| 74183 | <1% | 34 | $5K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 191 | $5K |
| 81206 | <1% | 65 | $5K | |
| 96116 | <1% | 316 | $5K | |
| 85730 | <1% | 828 | $5K | |
| 99423 | <1% | 308 | $5K | |
| 99177 | <1% | 3,741 | $4K | |
| 31231 | <1% | 14 | $4K | |
| 76870 | <1% | 150 | $4K | |
| 99201 | <1% | 517 | $4K | |
| 72081 | <1% | 497 | $4K | |
| 73060 | <1% | 256 | $4K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 40 | $4K |
| 77073 | <1% | 131 | $4K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 180 | $4K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 13 | $3K |
| 72220 | <1% | 191 | $3K | |
| 87210 | <1% | 4,514 | $3K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 174 | $3K |
| 92134 | <1% | 131 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 227 | $3K |
| 99205 | Prolong outpt/office vis | <1% | 154 | $3K |
| 81002 | <1% | 1,571 | $3K | |
| 73070 | <1% | 269 | $3K | |
| 64615 | <1% | 14 | $3K | |
| 93320 | <1% | 102 | $3K | |
| 73650 | <1% | 184 | $3K | |
| 70544 | <1% | 26 | $3K | |
| 81243 | <1% | 229 | $2K | |
| 93272 | <1% | 54 | $2K | |
| 93280 | <1% | 13 | $2K | |
| 90648 | <1% | 1,299 | $2K | |
| 93325 | <1% | 130 | $2K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 48 | $2K |
| 92133 | <1% | 98 | $2K | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 461 | $2K |
| G0127 | Trimming of dystrophic nails, any number | <1% | 74 | $2K |
| 82550 | <1% | 450 | $2K | |
| 88304 | <1% | 314 | $2K | |
| 99417 | Prolong home eval add 15m | <1% | 93 | $2K |
| 96156 | <1% | 41 | $2K | |
| 93304 | <1% | 55 | $2K | |
| 93018 | <1% | 81 | $2K | |
| 82105 | <1% | 264 | $2K | |
| 72082 | <1% | 30 | $2K | |
| 97165 | <1% | 40 | $2K | |
| 0083A | <1% | 104 | $1K | |
| 97166 | <1% | 42 | $1K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 37 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 346 | $1K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 41 | $1K |
| 70220 | <1% | 63 | $1K | |
| 83835 | <1% | 49 | $998.75 | |
| 99234 | <1% | 27 | $883.72 | |
| 20552 | <1% | 12 | $835.01 | |
| 90723 | <1% | 208 | $777.00 | |
| 96040 | <1% | 281 | $736.00 | |
| 87338 | <1% | 633 | $657.60 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 39 | $631.68 |
| 80177 | <1% | 113 | $610.70 | |
| 82985 | <1% | 204 | $589.68 | |
| 99051 | <1% | 55,449 | $571.71 | |
| 0034A | <1% | 13 | $543.30 | |
| 96112 | <1% | 41 | $520.00 | |
| 76801 | <1% | 44 | $517.37 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 813 | $500.00 |
| 81025 | <1% | 156 | $486.25 | |
| 81015 | <1% | 209 | $483.48 | |
| 88342 | <1% | 24 | $476.75 | |
| 80175 | <1% | 208 | $463.08 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 42 | $441.89 |
| 85652 | <1% | 248 | $414.85 | |
| 83605 | <1% | 150 | $380.29 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 104 | $376.65 |
| 72080 | <1% | 12 | $362.83 | |
| 82962 | <1% | 140 | $352.69 | |
| 92083 | <1% | 18 | $350.00 | |
| 99188 | <1% | 150 | $348.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 37 | $338.80 |
| 83735 | <1% | 59 | $330.00 | |
| 86141 | <1% | 43 | $300.00 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 107 | $296.00 |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 173 | $285.00 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $285.00 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 39 | $282.00 |
| 51798 | <1% | 25 | $270.85 | |
| 0173A | <1% | 57 | $268.50 | |
| 82040 | <1% | 142 | $260.00 | |
| 72052 | <1% | 13 | $220.00 | |
| 82950 | <1% | 205 | $215.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 671 | $201.42 |
| 90655 | <1% | 58 | $196.00 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 25 | $180.00 |
| 81001 | <1% | 40 | $178.96 | |
| 90633 | <1% | 89 | $177.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 113 | $169.00 |
| 96127 | <1% | 122 | $136.00 | |
| 92587 | <1% | 25 | $124.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 90 | $123.51 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 12 | $94.84 |
| 84590 | <1% | 278 | $79.00 | |
| 82085 | <1% | 54 | $78.54 | |
| 96150 | <1% | 18 | $75.20 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 801 | $60.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 32 | $59.15 |
| 99462 | <1% | 742 | $54.44 | |
| 84155 | <1% | 22 | $50.00 | |
| 84156 | <1% | 15 | $50.00 | |
| 84550 | <1% | 34 | $50.00 | |
| 84305 | <1% | 14 | $30.24 | |
| 82435 | <1% | 12 | $30.00 | |
| 82374 | <1% | 12 | $30.00 | |
| D1206 | Topical application of fluoride varnish | <1% | 29 | $17.82 |
| 84403 | <1% | 27 | $10.08 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 12 | $1.06 |
| G9920 | Screening performed and negative | <1% | 6,926 | $0.18 |
| 99024 | 0% | 1,220 | $0.00 | |
| 1036F | 0% | 39,579 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 48 | $0.00 |
| 3074F | 0% | 104 | $0.00 | |
| 94660 | 0% | 20 | $0.00 | |
| 99460 | 0% | 16 | $0.00 | |
| 86780 | 0% | 41 | $0.00 | |
| 3044F | 0% | 815 | $0.00 | |
| 95806 | 0% | 44 | $0.00 | |
| 87340 | 0% | 15 | $0.00 | |
| 82728 | 0% | 68 | $0.00 | |
| 82043 | 0% | 293 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 305 | $0.00 |
| 87081 | 0% | 29 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 15 | $0.00 |
| 87088 | 0% | 308 | $0.00 | |
| 83550 | 0% | 54 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 118 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 12 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 13 | $0.00 |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 0% | 25 | $0.00 |
| 29700 | 0% | 12 | $0.00 | |
| 86140 | 0% | 13 | $0.00 | |
| 82607 | 0% | 57 | $0.00 | |
| 92227 | 0% | 137 | $0.00 | |
| 83993 | 0% | 13 | $0.00 | |
| 84153 | 0% | 15 | $0.00 | |
| 80061 | Lipid panel | 0% | 372 | $0.00 |
| 82274 | 0% | 192 | $0.00 | |
| 90661 | 0% | 1,628 | $0.00 | |
| 84439 | 0% | 102 | $0.00 | |
| 3078F | 0% | 89 | $0.00 | |
| 87186 | 0% | 57 | $0.00 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 0% | 143 | $0.00 |
| 99307 | 0% | 21 | $0.00 | |
| 83540 | 0% | 67 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 49 | $0.00 |
| 3046F | 0% | 34 | $0.00 | |
| 84100 | 0% | 16 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 35 | $0.00 |
| 90756 | 0% | 26 | $0.00 | |
| 96153 | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIDOFF, RAMIN (EXECUTIVE MEDICAL DIRECTOR)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.